These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 12624605

  • 1. The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients.
    Antikainen R, Grodzicki T, Palmer AJ, Beevers DG, Coles EC, Webster J, Bulpitt CJ.
    J Hum Hypertens; 2003 Mar; 17(3):159-64. PubMed ID: 12624605
    [Abstract] [Full Text] [Related]

  • 2. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B.
    Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular hypertrophy by Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects.
    Antikainen RL, Grodzicki T, Beevers DG, Webster J, Jokelainen JJ, Bulpitt CJ.
    J Hum Hypertens; 2009 Jan; 23(1):20-6. PubMed ID: 18754020
    [Abstract] [Full Text] [Related]

  • 4. Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?
    Antikainen RL, Grodzicki T, Palmer AJ, Beevers DG, Webster J, Bulpitt CJ, Department of Health and Social Security Hypertension Care Computer Project (DHCCP).
    J Hum Hypertens; 2006 Jun; 20(6):451-9. PubMed ID: 16708082
    [Abstract] [Full Text] [Related]

  • 5. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B, LIFE Study Group.
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [Abstract] [Full Text] [Related]

  • 6. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
    Okin PM, Wright JT, Nieminen MS, Jern S, Taylor AL, Phillips R, Papademetriou V, Clark LT, Ofili EO, Randall OS, Oikarinen L, Viitasalo M, Toivonen L, Julius S, Dahlöf B, Devereux RB.
    Am J Hypertens; 2002 Aug; 15(8):663-71. PubMed ID: 12160187
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 Aug; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania.
    Lutale JJ, Thordarson H, Gulam-Abbas Z, Vetvik K, Gerdts E.
    Cardiovasc J Afr; 2008 Aug; 19(1):8-14. PubMed ID: 18320079
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR, Cea-Calvo L, Bertomeu V, Aznar J, for Investigators study VIIDA.
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Feb; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.
    Snelder SM, van de Poll SWE, de Groot-de Laat LE, Kardys I, Zijlstra F, van Dalen BM.
    Clin Cardiol; 2020 May; 43(5):483-490. PubMed ID: 31990994
    [Abstract] [Full Text] [Related]

  • 19. Determinants and improvement of electrocardiographic diagnosis of left ventricular hypertrophy in a black African population.
    Jingi AM, Noubiap JJ, Kamdem P, Kingue S.
    PLoS One; 2014 May; 9(5):e96783. PubMed ID: 24810594
    [Abstract] [Full Text] [Related]

  • 20. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.
    Mahn JJ, Dubey E, Brody A, Welch R, Zalenski R, Flack JM, Ference B, Levy PD.
    Acad Emerg Med; 2014 Sep; 21(9):996-1002. PubMed ID: 25269580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.